OQS
ABBV icon

Occudo Quantitative Strategies’s AbbVie ABBV Stock Holding History

Occudo Quantitative Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,187
Closed -$449K – 722
2020
Q4 		$449K Buy
+4,187
New +$402K 0.14% 273

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Occudo Quantitative Strategies's ABBV Position: Q1 2021 in Review

Occudo Quantitative Strategies sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 4,187 shares — an estimated $449K sold.

Occudo Quantitative Strategies first reported a position in ABBV in Q4 2020 and held it in 1 quarter. The position peaked at $449K in Q4 2020. 2,615 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

  • Occudo Quantitative Strategies reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 4,187 AbbVie shares in Q1 2021, an estimated $449K.
  • Occudo Quantitative Strategies first reported a position in AbbVie in Q4 2020 and held it in 1 quarter.
  • Occudo Quantitative Strategies's AbbVie position peaked at $449K in Q4 2020.
  • 2,615 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2021, filed 14 May 2021.